ID   HeLa-tat-III/CMV/d1EGFP
AC   CVCL_1H26
SY   HeLa-Tat-III/CMV/d1EGFP
DR   HIVReagentProgram; ARP-11062
DR   Wikidata; Q54882732
RX   PubMed=15498776;
CC   Population: African American.
CC   Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1H25 ! HeLa-tat-III
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 11
//
RX   PubMed=15498776; DOI=10.1074/jbc.M408435200;
RA   Parent M., Yung T.M.C., Rancourt A., Ho E.L.Y., Vispe S.,
RA   Suzuki-Matsuda F., Uehara A., Wada T., Handa H., Satoh M.S.;
RT   "Poly(ADP-ribose) polymerase-1 is a negative regulator of HIV-1
RT   transcription through competitive binding to TAR RNA with Tat.positive
RT   transcription elongation factor b (p-TEFb) complex.";
RL   J. Biol. Chem. 280:448-457(2005).
//